Big Gain For Exagen Inc.
Exagen Inc. (XGN:NASDAQ) soared at $3.4, a gain of 32.8%. The stock got featured on our News Catalysts scanner on Mon, Nov 14, 2022 at 05:35 PM in the 'EARNINGS' category. From Wed, Nov 09, 2022, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Wed, Nov 16, 2022 at $4.2 with a volume of 1M+.
About Exagen Inc. (XGN:NASDAQ)
Exagen Diagnostics Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets four products under its Avise brand to provide an accurate, timely and differential diagnosis and to optimize the treatment of ARDs. It processed approximately 9,300 patient specimens for its diagnostic product line, Avise SLE. It markets and sells solutions to community rheumatologists.
Top 10 Gainers:
- Kalera Public Limited Company (KAL:NASDAQ), 76.92%
- Venus Concept Inc. (VERO:NASDAQ), 59.96%
- Porch Group Inc. (PRCH:NASDAQ), 40.94%
- Perfect Corp. Class A (PERF:NYSE), 39.28%
- NLS Pharmaceutics Ltd. (NLSP:NASDAQ), 38.46%
- NeuroBo Pharmaceuticals, Inc. (NRBO:NASDAQ), 35.83%
- TeraWulf Inc. (WULF:NASDAQ), 33.59%
- Exagen Inc. (XGN:NASDAQ), 32.81%
- The Very Good Food Company Inc. (VGFC:NASDAQ), 31.92%
- XL Group Ltd (XL:NYSE), 30.91%